Literature DB >> 22277956

Simple and rapid purification of pediocin PA-1 from Pediococcus pentosaceous NCDC 273 suitable for industrial application.

B Vijay Simha1, S K Sood, Rashmi Kumariya, Anita Kumari Garsa.   

Abstract

The use of pediocins as food additives or drugs requires a simple and rapid method by which large quantities of homogeneous pediocin are produced at industrial level. Two centrifugation steps required during initial stages of purification i.e. separation of cells from fermentation broth and collection of precipitates after ammonium sulphate precipitation are the major bottlenecks for their large scale purification. In the present work, pediocin production by a new a dairy strain, Pediococcus pentosaceous NCDC 273 (identical to pediocin PA-1 at nucleotide sequence level), was found to be optimum at initial pH of 6.0 and 7.0 of basal MRS supplemented with 20 g/l of glucose or lactose at 20 and 24 h, respectively. Immobilization of cells through entrapment in alginate-xanthan gum gel beads with chitosan coating resulted in negligible cell release during fermentation. Thus, the cell free extract was directly collected through decantation, avoiding the need of centrifugation step at this stage. Subsequent ammonium sulphate precipitation at isoelectric point of pediocin PA-1 (8.85), using magnetic stirrer at high speed (approx. 1200 rpm), resulted in forceful deposition of precipitates on the wall of precipitation beaker allowing their collection using a spatula, avoiding centrifugation step at this stage also. Further purification using cation-exchange chromatography resulted in yield of 134.4% with more than 320 fold purification with the specific activity of 19×10⁵ AU/mg. The collection of single peak of pediocin at 41.9min in RP-HPLC, overlapping with standard pediocin PA-1, resulted in yield of 1.15 μg from 20 μl of sample applied. The overlapping of RP-HPLC peak and SDS-PAGE band corresponding to 4.6 kDa, confirmed the purity and identity of pediocin 273 as pediocin PA-1.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22277956     DOI: 10.1016/j.micres.2012.01.001

Source DB:  PubMed          Journal:  Microbiol Res        ISSN: 0944-5013            Impact factor:   5.415


  10 in total

1.  Analysis of Bacterial Diversity During Acetic Acid Fermentation of Tianjin Duliu Aged Vinegar by 454 Pyrosequencing.

Authors:  Qian Peng; Yanping Yang; Yanyun Guo; Ye Han
Journal:  Curr Microbiol       Date:  2015-04-24       Impact factor: 2.188

Review 2.  Bacteriocin production and different strategies for their recovery and purification.

Authors:  Anita Kumari Garsa; Rashmi Kumariya; S K Sood; Anil Kumar; Suman Kapila
Journal:  Probiotics Antimicrob Proteins       Date:  2014-03       Impact factor: 4.609

Review 3.  Application of Bacteriocins and Protective Cultures in Dairy Food Preservation.

Authors:  Célia C G Silva; Sofia P M Silva; Susana C Ribeiro
Journal:  Front Microbiol       Date:  2018-04-09       Impact factor: 5.640

4.  LHH1, a novel antimicrobial peptide with anti-cancer cell activity identified from Lactobacillus casei HZ1.

Authors:  Jun-Fang He; Du-Xin Jin; Xue-Gang Luo; Tong-Cun Zhang
Journal:  AMB Express       Date:  2020-11-11       Impact factor: 3.298

5.  A bacteriocin-based antimicrobial formulation to effectively disrupt the cell viability of methicillin-resistant Staphylococcus aureus (MRSA) biofilms.

Authors:  Christian Kranjec; Kirill V Ovchinnikov; Torstein Grønseth; Kumar Ebineshan; Aparna Srikantam; Dzung B Diep
Journal:  NPJ Biofilms Microbiomes       Date:  2020-12-02       Impact factor: 7.290

Review 6.  Bacteriocins: Properties and potential use as antimicrobials.

Authors:  Atieh Darbandi; Arezoo Asadi; Marzieh Mahdizade Ari; Elnaz Ohadi; Malihe Talebi; Masoume Halaj Zadeh; Amir Darb Emamie; Roya Ghanavati; Maryam Kakanj
Journal:  J Clin Lab Anal       Date:  2021-12-01       Impact factor: 2.352

Review 7.  Microbiome therapeutics: exploring the present scenario and challenges.

Authors:  Monika Yadav; Nar Singh Chauhan
Journal:  Gastroenterol Rep (Oxf)       Date:  2021-11-15

8.  Screening beneficial bacteriostatic lactic acid bacteria in the intestine and studies of bacteriostatic substances.

Authors:  Zhijing Liu; Cong Xu; Ran Tian; Wan Wang; Jiage Ma; Liya Gu; Fei Liu; Zhanmei Jiang; Juncai Hou
Journal:  J Zhejiang Univ Sci B       Date:  2021-07-15       Impact factor: 3.066

9.  Emerging Applications of Bacteriocins as Antimicrobials, Anticancer Drugs, and Modulators of The Gastrointestinal Microbiota.

Authors:  Catherine Cesa-Luna; Julia-María Alatorre-Cruz; Ricardo Carreño-López; Verónica Quintero-Hernández; Antonino Baez
Journal:  Pol J Microbiol       Date:  2021-06-21

10.  Physico-chemical and cytotoxic analysis of a novel large molecular weight bacteriocin produced by Lactobacillus casei TA0021.

Authors:  Elham Noroozi; Naheed Mojgani; Elahe Motevaseli; Mohammad Hossein Modarressi; Majid Tebianian
Journal:  Iran J Microbiol       Date:  2019-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.